Sygehus Soenderjylland Soenderborg
- Address
- lock Available on a paid plan
Sygehus Soenderjylland Soenderborg - Comprehensive Oncology & Cardiovascular Research Center
Sygehus Soenderjylland Soenderborg is a leading clinical research facility with extensive expertise in oncology and cardiovascular disease research. The center demonstrates particular strength in breast cancer research, participating in multiple international trials investigating novel therapies across all stages of the disease, from early-stage to advanced/metastatic presentations. The facility also conducts significant work in critical care medicine and cardiac conditions, reflecting a broad commitment to advancing treatment options across multiple therapeutic areas.
- Breast cancer therapeutics including hormone receptor-positive, HER2-negative, and triple-negative subtypes with focus on targeted therapies and immunotherapy combinations
- Cardiovascular interventions including acute coronary syndromes, mechanical valve anticoagulation management, and hypertrophic cardiomyopathy treatments
- Lung cancer research with emphasis on KRAS-mutated and small cell lung cancer novel treatment regimens
- Gastrointestinal oncology, metabolic disorders, and critical care platform trials
The center's research portfolio encompasses both neoadjuvant and adjuvant treatment strategies, demonstrating expertise in precision medicine approaches with molecular marker-driven therapies. Research activities include evaluation of vasomotor symptom management in breast cancer patients, pediatric gastroenterology, and innovative imaging modalities for treatment monitoring. This diverse clinical trial portfolio positions Sygehus Soenderjylland Soenderborg as a comprehensive research institution contributing to evidence-based advances across multiple medical specialties.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Region Hovedstaden1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sygehus Soenderjylland Soenderborg
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Bicarbonate for In-Hospital Cardiac Arrest – A Randomized, Double-Blind, Placebo-Controlled Trial | Region Midtjylland | Phase III | Not Recruiting | Feb 2023 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sodium Chloride | 1 | Unknown | 2023-02-06 | 2023-02-06 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.